Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

Neuropsychiatric systemic lupus erythematosus (NPSLE), or central nervous system lupus, can be challenging to diagnose ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

A study reveals caffeine's potential to enhance heart health by improving endothelial function in systemic lupus ...

Preconception predictors of adverse pregnancy outcomes among women with SLE include previous lupus nephritis, chronic hypertension, SLE disease activity, and APS.

Clinical research has shown that patients with systemic lupus erythematosus (SLE) are more likely to develop cardiovascular ...

Doctors in Hangzhou, Zhejiang province, have successfully completed the world's largest clinical study of involving the use ...

Adult patients hospitalized for aseptic or septic revision TKA were eligible for inclusion. Patients with SLE were propensity score matched in a 1:4 ratio with individuals without the disease. The ...

New research suggests that higher daily intakes of ultraprocessed foods (UPFs) are associated with a higher risk of ...

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...